VRS
PCVX icon

Virginia Retirement Systems’s Vaxcyte PCVX Stock Holding History

Virginia Retirement Systems’s Portfolio PCVX Stock Details PCVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-10,500
Closed -$341K – 1022
2025
Q2 		$341K Buy
10,500
+3,100
+42% +$102K ﹤0.01% 820
2025
Q1 		$279K Buy
+7,400
New +$592K ﹤0.01% 897

Other funds holding PCVX

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

Virginia Retirement Systems's PCVX Position: Q3 2025 in Review

Virginia Retirement Systems sold out of Vaxcyte (PCVX) in Q3 2025, closing a stake of 10,500 shares — an estimated $341K sold.

Virginia Retirement Systems first reported a position in PCVX in Q1 2025 and held it in 2 quarters. The position peaked at $341K in Q2 2025. 285 funds tracked by Wall St. Rank hold PCVX as of Q3 2025.

  • Virginia Retirement Systems reported no remaining Vaxcyte position as of Q3 2025 after selling out during the quarter.
  • Virginia Retirement Systems sold 10,500 Vaxcyte shares in Q3 2025, an estimated $341K.
  • Virginia Retirement Systems first reported a position in Vaxcyte in Q1 2025 and held it in 2 quarters.
  • Virginia Retirement Systems's Vaxcyte position peaked at $341K in Q2 2025.
  • 285 funds tracked by Wall St. Rank held Vaxcyte as of Q3 2025.

Based on Virginia Retirement Systems's 13F filing for Q3 2025, filed 20 Oct 2025.